Fei Fah Medical Manufacturing recalls ULTRA STRENTGH, ELECTRIC MIDICATED BALM over manufacturing practice problems
The notice says the balm (menthol 16% and methyl salicylate 32%) was recalled because of CGMP deviations, and 171,120 units were sold nationwide within the U.S.
What to do
The notice does not give instructions. Read the official notice for details.
Note from Recalled Today: Don't stop taking a prescribed medicine before you talk to your pharmacist or doctor.
Recall details
- Product
- ULTRA STRENTGH, ELECTRIC MIDICATED BALM (menthol 16% and methyl salicylate 32%) packaged in a) Net 2.45 oz (70g) (NDC 63299-001-01) and b) 10g (NDC 63299-001-02), Manufactured by Fei Fah Medical Mfg Pte Ltd, Singapore, U.S Distributor: SOLISTICE MEDICINE COMPANY, 215 West Ann Street, Los Angeles, CA 90012
- Hazard
- CGMP Deviations
- Units
- 171,120 units
- Where sold
- Nationwide within the U.S
- FDA classification
- Class II · Ongoing
- Classified by FDA
- October 27, 2026
- Recall started
- October 23, 2026
- FDA enforcement report
- November 4, 2026
- Identifiers
- Codes: Lot: a)23FEBU7001-019, Exp. Date: October 2028; 24FEBU7001-020, Exp. Date: November 2029. b) 23FEBU1001-9, Exp. Date: October 2028; 24FEBU1001-004, Exp. Date: November 2029.
- FDA recall number: D-0104-2027
The headline, summary and steps above are written in plain English from the official notice below. Identifiers are copied exactly as the agency published them. Always check the official notice before you act.
Official notice
The notice's own wording from FDA.
- Product
- ULTRA STRENTGH, ELECTRIC MIDICATED BALM (menthol 16% and methyl salicylate 32%) packaged in a) Net 2.45 oz (70g) (NDC 63299-001-01) and b) 10g (NDC 63299-001-02), Manufactured by Fei Fah Medical Mfg Pte Ltd, Singapore, U.S Distributor: SOLISTICE MEDICINE COMPANY, 215 West Ann Street, Los Angeles, CA 90012
- Reason for recall
- CGMP Deviations
- Classification
- Class II (Ongoing)
- Distribution
- Nationwide within the U.S
- Quantity
- 171,120 units
Related recalls
Dabur India recalls hydrocortisone cream and triple antibiotic ointments over manufacturing rule violations
The FDA found deficiencies in good manufacturing practices at the maker during an inspection, which affects these creams and ointments sold under the Med Pride, Rapidol and Lucky Super Soft names.
Dabur India Limited · 41,419 units
Ajanta Pharma recalls Fenofibrate Capsules, USP 200 mg over manufacturing practice deviations
The notice says these Fenofibrate Capsules, USP 200 mg, in 100-capsule bottles are being recalled because of CGMP deviations, and 3648 bottles were sold across the U.S.
Ajanta Pharma USA Inc · 3648 bottles